4 . acquisitions and dispositions acquisitions the company makes acquisitions that align with its strategic business objectives . the assets and liabilities of the acquired entities have been recorded as of the acquisition date , at their respective fair values , and are included in the consolidated balance sheet . the purchase price allocation is based on estimates of the fair value of assets acquired and liabilities assumed . the aggregate purchase price of acquisitions has been reduced for any cash or cash equivalents acquired with the acquisition . acquisitions during 2017 , 2016 and 2015 were not significant to the company 2019s consolidated financial statements ; therefore , pro forma financial information is not presented . anios acquisition on february 1 , 2017 , the company acquired anios for total consideration of $ 798.3 million , including satisfaction of outstanding debt . anios had annualized pre-acquisition sales of approximately $ 245 million and is a leading european manufacturer and marketer of hygiene and disinfection products for the healthcare , food service , and food and beverage processing industries . anios provides an innovative product line that expands the solutions the company is able to offer , while also providing a complementary geographic footprint within the healthcare market . during 2016 , the company deposited 20ac50 million in an escrow account that was released back to the company upon closing of the transaction in february 2017 . as shown within note 5 , this was recorded as restricted cash within other assets on the consolidated balance sheet as of december 31 , 2016 . the company incurred certain acquisition and integration costs associated with the transaction that were expensed and are reflected in the consolidated statement of income . see note 3 for additional information related to the company 2019s special ( gains ) and charges related to such activities . the components of the cash paid for anios are shown in the following table. .
|( millions )|2017|
|tangible assets|$ 139.8|
|identifiable intangible assets||
|customer relationships|252.0|
|trademarks|65.7|
|other technology|16.1|
|total assets acquired|473.6|
|goodwill|511.7|
|total liabilities|187.0|
|total consideration transferred|798.3|
|long-term debt repaid upon close|192.8|
|net consideration transferred to sellers|$ 605.5|
tangible assets are primarily comprised of accounts receivable of $ 64.8 million , property , plant and equipment of $ 24.7 million and inventory of $ 29.1 million . liabilities primarily consist of deferred tax liabilities of $ 102.3 million and current liabilities of $ 62.5 million . customer relationships , trademarks and other technology are being amortized over weighted average lives of 20 , 17 , and 11 years , respectively . goodwill of $ 511.7 million arising from the acquisition consists largely of the synergies and economies of scale expected through adding complementary geographies and innovative products to the company 2019s healthcare portfolio . the goodwill was allocated to the institutional , healthcare , and specialty operating segments within the global institutional reportable segment and the food & beverage and life sciences operating segments within the global industrial reportable segment . none of the goodwill recognized is expected to be deductible for income tax purposes. .

Question: what portion of anios' purchasing price is related to goodwill?
Answer: 0.84509